The Effect of Coronavirus Outbreak on the Utilization of Coronary Revascularization Procedures: An Interrupted Time Series Analysis.
Antonio Sarria-SantameraAlexandr PetrovDinara YessimovaMiguel Ángel OrtegaSaule ZhumambayevaAngel Asúnsolo-Del BarcoPublished in: Journal of cardiovascular development and disease (2023)
The coronavirus disease 19 (COVID-19) pandemic represented a great challenge for health systems, which had to quickly readapt and dedicate most of their resources to managing this crisis. The postponement of programmed interventions such as coronary revascularization procedures represented a critical issue in the first wave of the COVID-19 pandemic, especially in the hardest-hit countries such as Spain. However, the precise consequences of the delay of coronary revascularizations are not clearly determined. In the present work, interrupted time series (ITS) analysis was used to evaluate the utilization rates and assessment of the risk profiles of patients receiving two main coronary revascularization procedures (percutaneous coronary intervention-PCI and coronary artery bypass graft-CABG) and compared them in the periods before and after March 2020 using the Spanish National Hospital Discharge Database (SNHDD). Our results show that the abrupt reorganization of hospital care that represented the first wave of COVID-19 in March 2020 in Spain led to a reduction in cases, which was accompanied by an increase in the risk profile of CABG patients, but not PCI. On the other hand, the risk profile of both coronary revascularization procedures began before the pandemic, showing a significant temporal trend toward an increase in the risk profile. Future works should be directed to study and validate our results, evaluating other databases, regions, or countries.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- coronary artery bypass grafting
- coronary artery bypass
- coronavirus disease
- st segment elevation myocardial infarction
- coronary artery
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- sars cov
- end stage renal disease
- physical activity
- chronic kidney disease
- atrial fibrillation
- heart failure
- palliative care
- artificial intelligence
- aortic stenosis
- machine learning
- left ventricular
- public health
- newly diagnosed
- chronic pain
- health insurance
- quality improvement
- respiratory syndrome coronavirus
- aortic valve
- adverse drug